Cantor Fitzgerald Lowers CoreWeave Price Target to $100

Analyst: Brett Knoblauch 1 min read Reproduced verbatim
Rating
Overweight
Target
$100
from $176 (−43%)
Upside
+153%
CRWV at $39.51 today

10th-lowest of 28 current targets on CoreWeave, 10% below the $111 median. Cantor has reached 78% of its year-old targets (59 scored).

What the analyst said

Cantor Fitzgerald analyst Brett Knoblauch lowered the price target on CoreWeave (NASDAQ: CRWV) to $100 (from $176) while maintaining an Overweight rating.

“Coming into the print, the debate centered on how CRWV funds its build after recent volatility in the capital markets, and mgmt laid out a funding plan through 2027 that we believe addresses it. CRWV will not issue unsecured debt at current yields through 2027 and expects to raise 90% of associated capex, and >75% of committed capex through 2027 is tied to investment-grade and enterprise customers.

CRWV expects to collect ~$9bn of prepayments and deposits over the next three months, >$3bn of which relates to recontracting paid down infrastructure with no debt service attached. Mgmt reaffirmed that contracted cash flow covers service and repayment of all existing and planned debt before counting renewals.

Revenue and adjusted EBITDA beat consensus (FactSet) by 3.3% and 10.9%, respectively. Backlog growth implied ~$32bn of new bookings in the quarter. Combined with pricing moving higher across every GPU generation and ~300k GPUs rolling off paid down contracts across 2027 and 2028, we see upside to our 2027 and 2028 estimates.

We reiterate our Overweight rating and raise our 2026/2027/2028 estimates on stronger demand, but lower our PT to $100 (from $176) given the de-rating that has occurred across the AI cloud sector. We now value CRWV at 14x 2028E EV/EBIT, vs previously at 8.5x 2027E EV/ EBITDA.

Ultimately, the combination of a strong print and management highlighting robust access to capital should alleviate the bulk of pressing investor concerns, in our view.”

Cite this note: Price Target, "Cantor Fitzgerald Lowers CoreWeave Price Target to $100," November 11, 2026. https://price-target.com/2026/11/11/179551/
Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

CRWV trades at $39.51. The 28 analysts who set a target in the last 3 months range from $39 to $200, with a median of $111. This $100 target is 10% below the median.

Since the note CRWV has moved −19% (from $48.73). 12-month window: day 9 of 365, closes on November 11, 2027.

Track record

This callOpen: CRWV has not reached $100 yet. This 12-month target is scored on November 11, 2027.

Firm track recordCantor: 78% of its 59 targets at least a year old were reached within 12 months (#15 of 29 firms). Accuracy ranking →

Earnings reactionOne of 13 notes after CoreWeave’s Nov 10 results: 1 raised · 8 cut · 4 kept. See every call →

Cantor on CoreWeave

Cantor price targets on CoreWeave

7 calls from August 12, 2026 to November 11, 2026. The target went from $178 to $100 (−44%). The rating stayed Buy.

Cantor targetCRWV share price
  1. November 11, 2026 This noteTarget cut from $176 (−43%)Buy$100
  2. October 26, 2026Kept the $176 targetBuy$176
  3. October 19, 2026Kept the $176 targetBuy$176
  4. October 16, 2026Kept the $176 targetBuy$176
  5. October 2, 2026Kept the $176 targetBuy$176
  6. September 28, 2026Target cut from $178 (−1%)Buy$176
  7. August 12, 2026Earliest call shownBuy$178
Share Reddit StockTwits
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.